molecules of the month


potent, non-oral CGRP antagonist

clean profile in 10-day rodent tox.

from SBDD of prior ligand

J. Med. Chem., Jul. 23, 2020

Sosei Heptares, Cambridge, UK

Structure of CGRP receptor agonist HTL22562
1 min read

HTL22562 is a CGRP antagonist intended to treat acute migraines. Some prior oral CGRP antagonists failed in clinical trials due to liver tox. signals, so this program targeted a non-oral candidate with lower first-pass liver exposure that might avoid such issues. Impressively the authors were able to drive the program through structure-based design thanks to X-ray co-crystal structures with the CGRP ectodomain complex. Structure-guided programs have been rare for membrane-bound proteins like GPCRs due to the challenge in crystallizing relevant forms of these targets.

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: